Among men treated with prostatectomy or radiation therapy for localized prostate cancer, the
state of an increasing prostate-specific antigen (PSA) level is known as biochemical …

Prostate cancer has come to share the oncological centrestage among male cancers. The
availability of Serum Prostate Specific Antigen, PSA, as a marker has encouraged it's use to …

Third Edition brings the text up to date with new material and updated references. New
content includes an introduction to left and interval censored data; the log-logistic …

In 1996 the American Society for Therapeutic Radiology and Oncology (ASTRO) sponsored
a Consensus Conference to establish a definition of biochemical failure after external beam …

Background We sought to identify determinants of health-related quality of life after primary
treatment of prostate cancer and to measure the effects of such determinants on satisfaction …

Background In men with localised prostate cancer, conformal radiotherapy (CFRT) could
deliver higher doses of radiation than does standard-dose conventional radical external …

Purpose Prostate-specific antigen (PSA) defined biochemical recurrence (BCR) of prostate
cancer is widely used for reporting the outcome of radical prostatectomy (RP). A …

Purpose: Brenner and Hall's 1999 paper estimating an α/β value of 1.5 Gy for prostate
tumors has stimulated much interest in the question of whether this ratio (of intrinsic …

Purpose: To report the acute and late toxicity and preliminary biochemical outcomes in 772
patients with clinically localized prostate cancer treated with high-dose intensity-modulated …

ContextSalvage radiotherapy may potentially cure patients with disease recurrence after
radical prostatectomy, but previous evidence has suggested that it is ineffective in patients at …